MICHAEL TORRES, Ph.D.

Vice President, R&D, Texas Site Head

Dr. Torres is a scientist and entrepreneur with significant experience in R&D, venture formation and fundraising, and biotech equity portfolio management.

Dr. Torres co-founded ReCode Therapeutics in 2017, where he has focused on drug discovery, platform validation and preclinical development. Previously, he was a senior consultant at Alpha BioPharma Advisers from 2015 to 2017. He oversaw the successful implementation of special projects and equity research at Alpha BioPharma Advisers. He was a postdoctoral fellow at UT Southwestern Medical Center from 2014 to 2017.

Dr. Torres received his B.S. in biology from Dallas Baptist University and his Ph.D. from UT Southwestern. He has authored 8 publications resulting in more than 300 citations and is inventor to technologies licensed to ReCode Therapeutics.